Aims: Our purpose was to clarify the effect of sulfamethoxazole (SMX) on the startup period, particle formation, and treatment efficiency of an aerobic granular sludge system. Methods and Results:We compared an R1 granular sequencing batch reactor (GSBR) started with 5 μg L −1 SMX and an R2 GSBR started without SMX, as a control, to investigate the impact of a trace amount of SMX (5 μg L −1 ) on aerobic granular sludge (AGS) characteristics and the removal of conventional contaminants. AGS granulation in the R1 system was not inhibited by SMX, but the granule particle size was smaller than that in the R2 system. Both systems had good performance removing conventional pollutants. Extracellular polymeric substance secretion in the R1 system was lower than that in the R2 system. After stabilizing reactor operations, the SMX removal efficiency in the R1 system (~73.93%) was higher than that in the R2 system (~70.66%). The start-up modes also determined the differences in the microbial community structure of the AGS systems. Conclusions: SMX-activated AGS performed better than AGS without SMX. Significance and Impact of Study:The study can help engineers determine startup modes with varieties of antibiotics in AGS processes and provide references for the optimization of water treatment processes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.